Mediterranean Diet and Physical Activity in Breast Cancer Patients Under Hormone Therapy
NCT07443787 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150
Last updated 2026-03-02
Summary
This study aims to evaluate body weight status, lifestyle patterns, and cardiometabolic risk in women in remission from breast cancer undergoing adjuvant hormone therapy, and to assess the effects of a structured nutritional intervention based on the Mediterranean diet combined with physical activity promotion.
A total of 150 women treated with adjuvant hormone therapy are recruited from the oncology department of Akid Othmane Hospital in Oran, Algeria. Participants include women receiving tamoxifen or aromatase inhibitors. Baseline assessments include anthropometric measurements (body weight, body mass index, waist and hip circumferences), socioeconomic characteristics, and lifestyle evaluation.
Dietary intake is assessed using 24-hour dietary recalls and 3-day food records. Total energy intake, macronutrient and micronutrient composition, dietary habits, meal distribution, and adherence to the Mediterranean diet (MEDAS score) are evaluated. Physical activity level, sedentary behavior, daily energy expenditure, and energy balance are also determined.
Cardiometabolic risk is assessed through measurement of blood pressure, fasting blood glucose, lipid profile (total cholesterol, LDL-C, HDL-C, triglycerides), uric acid, albumin, creatinine, urea, and calculation of atherogenic ratios.
A structured educational program promoting adherence to the Mediterranean diet and increased physical activity is implemented. Anthropometric, dietary, lifestyle, and cardiometabolic parameters are monitored over time to evaluate changes associated with the intervention.
Conditions
Interventions
- BEHAVIORAL
-
Physical activity promotion
Counseling and structured recommendations to increase regular physical activity over a 3-month period.
- BEHAVIORAL
-
Mediterranean diet
Dietary counseling and guidance to promote adherence to the Mediterranean diet over a 3-month period.
Sponsors & Collaborators
-
University of Oran 1
collaborator OTHER -
MOHAMEDI Ilhem Sarra Manel
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-05-02
- Primary Completion
- 2025-02-26
- Completion
- 2025-06-24
Countries
- Algeria
Study Locations
More Related Trials
-
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
NCT01127295 ·Status: COMPLETED ·Phase: PHASE4
-
Exercise in Older Women With Breast Cancer During Systemic Therapy
NCT03656731 ·Status: COMPLETED ·Phase: NA
-
Confirmation of the Link Between Endocrine Disruptors Exposure and Breast Cancer and Identification of Biological Response Biomarkers
NCT07411651 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of a Clinical Nutrition Intervention Program in Breast Cancer Patients During Antineoplastic Treatment
NCT03625635 ·Status: UNKNOWN ·Phase: NA
-
Quality of Life and Sexuality of Patients Over 65 Years Undergoing Adjuvant Treatment for Breast Cancer
NCT03946579 ·Status: COMPLETED ·Phase: NA
-
Physical Activity and Breast Cancer Risk in Postmenopausal Women:the SHAPE Study
NCT00359060 ·Status: COMPLETED ·Phase: PHASE3
-
Therapeutic Education Intervention in Breast Cancer: PEPs Hormonotherapy
NCT02300675 ·Status: COMPLETED ·Phase: NA
-
A Study on Optimizing Follow-up for Postmenopausal Women With Breast Cancer Treated With Adjuvant Endocrine Therapy
NCT02935920 ·Status: COMPLETED ·Phase: NA
-
Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
NCT02088710 ·Status: UNKNOWN
-
Effects Of Concentric Cycling Training Protocol During (Neo)Adjuvant Chemotherapy in Breast Cancer Patients: PROTECT-07 Study
NCT06455904 ·Status: RECRUITING ·Phase: NA
-
ExclUsive endocRine Therapy Or Radiation theraPy for Women Aged ≥70 Years Early Stage Breast Cancer
NCT04134598 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Evaluating an AI-Based Mobile Application for Chemotherapy Support in Breast Cancer Patients
NCT07273812 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Sexual Quality of Life in Women During the First Year of Adjuvant Hormonal Treatment for Breast Cancer.
NCT04539587 ·Status: COMPLETED
-
eHealth Intervention for Medication Adherence in Breast Cancer Survivors
NCT05324020 ·Status: COMPLETED ·Phase: NA
-
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
NCT00003771 ·Status: COMPLETED ·Phase: PHASE3
-
Mediterranean Diet and Inequality in Early Breast Cancer
NCT07007169 ·Status: RECRUITING ·Phase: PHASE2
-
Prospective Observational Study of Adjuvant Hormone Treatment in Estrogen-receptor Positive Premenopausal Early Breast Cancer Patients
NCT05730647 ·Status: ACTIVE_NOT_RECRUITING
-
Activity Program During Aromatase Inhibitor Therapy
NCT03786198 ·Status: COMPLETED ·Phase: NA
-
Comparison of Cardiotoxicity Induced by Selective Estrogen REceptor Modulators and aNti-Aromatase
NCT03259711 ·Status: COMPLETED
-
Small-group, Virtual Program for Improving Symptoms and Distress Related to Hormonal Therapy for Breast Cancer Survivors
NCT03837496 ·Status: COMPLETED ·Phase: NA
-
Attenuating Cancer Treatment-related Toxicity in Oncology Patients With a Tailored Physical Exercise Program
NCT03787966 ·Status: COMPLETED ·Phase: NA
-
Preventing Breast Cancer Therapy-related Cardiovascular Toxicity With a Daily-adapted Program With Mhealth Support
NCT06518200 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Dietary Phytoestrogens, Complementary and Alternative Medicine, and Lifestyle in Predicting Survival of Women With Breast Cancer
NCT00691509 ·Status: UNKNOWN
-
Chronic Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer
NCT06776458 ·Status: RECRUITING
-
Evaluation of the Impact of a Pharmaceutical Interview on the Adherence to Hormonotherapy in Women With Breast Cancer
NCT04142476 ·Status: TERMINATED ·Phase: NA